Livermore, LPTN presented at Roth Conf, there is a webcast archive with slides
LPTN presented an update on iSONEP at the ROTH conference yesterday, there are slides, some cover the old trial results . There is a link to the webcast archive on the LPTN website.
I actually came across OHRP while researching LPTN last summer. I've followed them loosely since. LPTN CEO is a hypester, the antithesis of Dr. T. He likes to embellish the potential market opportunity of iSONEP more than he likes to talk the science. LPTN keeps pushing back the enrollment completion date for the Nexus PhII trial of iSONEP in we AMD. As of yesterday's presentation, they're not expecting trial results until the near the end of 2014. That is nearly a YEAR BEHIND ORIGINAL SCHEDULE.
I think they may be having trouble getting trial participants, strangely one of the arms in the PhII trial treats subjects with iSONEP alone (with no rescue injections of anti-VEGF). Would YOU want to be in the trial if there was a risk that you were treating your wet AMD with a potentially ineffective drug? Anyway, there seemed to be a wide deviation of efficacy among the patients and as you've said in the past, during presentations the CEO cherry picks the data to make results look better than they actually were.